Regulation of drug and palatable food overconsumption by similar peptide systems

Current Drug Abuse Reviews

Volumn 4, Issue 3, 2011, Pages 163-173

  Morganstern, Irene ^a   Barson, Jessica ^a   Leibowitz, Sarah ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Ethanol; Fat; Hypothalamus; Mesolimbic; Nicotine; Peptides

Indexed keywords

ALCOHOL; ENKEPHALIN; GALANIN; LIPID; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; NICOTINE; OREXIN; PEPTIDE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; AMYGDALOID NUCLEUS; CARBOHYDRATE INTAKE; DRUG SEEKING BEHAVIOR; DRUG USE; FOOD INTAKE; FOOD OVERCONSUMPTION; FOOD PREFERENCE; HUMAN; HYPERPHAGIA; HYPOTHALAMUS; LIMBIC CORTEX; LIPID DIET; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROCHEMISTRY; PALATABILITY; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFORCEMENT; REVIEW; RISK FACTOR; TOBACCO DEPENDENCE;

EID: 80055118110     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473711104030163     Document Type: Review

References (192)

1. Barson JR, Morganstern I, Leibowitz SF. Similarities in hypothalamic and mesocorticolimbic circuits regulating the overconsumption of food and alcohol. Physiol Behav 2011; 104(1): 128-137.
2. Leibowitz SF. Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides. Physiol Behav 2007; 91(5): 513-521.
3. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8(11): 1445-1449.
4. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 2011; 15(1): 37-46.
5. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999; 22(11): 521-527.
6. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 2006; 30(2): 215-238.
7. Liang NC, Hajnal A, Norgren R. Sham feeding corn oil increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 2006; 291(5): R1236-1239.
8. Rada P, Bocarsly ME, Barson JR, Hoebel BG, Leibowitz SF. Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet. Physiol Behav 2010; 101(3): 394-400.
9. Hajnal A, Norgren R. Accumbens dopamine mechanisms in sucrose intake. Brain Res 2001; 904(1): 76-84.
10. Rada P, Avena NM, Hoebel BG. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 2005; 134(3): 737-744.
11. Devine DP, Leone P, Wise RA. Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur J Pharmacol 1993; 243(1): 55-64.
12. Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 1992; 89(6): 2046-2050.
13. Bittencourt JC, Presse F, Arias C, et al. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 1992; 319(2): 218-245.
14. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95(1): 322-327.
15. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G proteincoupled receptors that regulate feeding behavior. Cell 1998; 92(4): 573-585.
16. Kaplan LM, Gabriel SM, Koenig JI, et al. Galanin is an estrogeninducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci U S A 1988; 85(19): 7408-7412.
17. Yoshikawa K, Williams C, Sabol SL. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J Biol Chem 1984; 259(22): 14301-14308.
18. Gehlert DR, Chronwall BM, Schafer MP, O'Donohue TL. Localization of neuropeptide Y messenger ribonucleic acid in rat and mouse brain by in situ hybridization. Synapse 1987; 1(1): 25-31.
19. Leibowitz SF, Wortley KE. Hypothalamic control of energy balance: different peptides, different functions. Peptides 2004; 25(3): 473-504.
20. Pickavance L, Dryden S, Hopkins D, et al. Relationships between hypothalamic neuropeptide Y and food intake in the lactating rat. Peptides 1996; 17(4): 577-582.
21. Leibowitz SF. Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis. Neuropeptides 2005; 39(3): 327-332.
22. Barson JR, Carr AJ, Soun JE, Sobhani NC, Leibowitz SF, Hoebel BG. Opioids in the nucleus accumbens stimulate ethanol intake. Physiol Behav 2009; 98(4): 453-459.
23. Morganstern I, Chang GQ, Chen YW, et al. Role of melaninconcentrating hormone in the control of ethanol consumption: Region-specific effects revealed by expression and injection studies. Physiol Behav 2010; 101(4): 428-437.
24. Schneider ER, Rada P, Darby RD, Leibowitz SF, Hoebel BG. Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcohol Clin Exp Res 2007; 31(11): 1858-1865.
25. Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behav Brain Res 2011; 217(2): 446-453.
26. Winrow CJ, Tanis KQ, Reiss DR, et al. Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 2010; 58(1): 185-194.
27. Chang GQ, Karatayev O, Barson JR, Chang SY, Leibowitz SF. Increased enkephalin in brain of rats prone to overconsuming a fatrich diet. Physiol Behav 2010; 101(3): 360-369.
28. Colombo G, Agabio R, Carai MA, et al. Different sensitivity to ethanol in alcohol-preferring sP and -nonpreferring sNP rats. Alcohol Clin Exp Res 2000; 24(11): 1603-1608.
29. Gahtan E, Labounty LP, Wyvell C, Carroll ME. The relationships among saccharin consumption, oral ethanol, and i.v. cocaine selfadministration. Pharmacol Biochem Behav 1996; 53(4): 919-925.
30. Gyekis J, Foreman JE, Anthony K, Klein LC, Vandenbergh DJ. Activity-related behaviors in the hole-board predict nicotine consumption in C57B6 mice perinatally exposed to nicotine. Behav Brain Res 2010; 206(1): 139-142.
31. Le AD, Li Z, Funk D, Shram M, Li TK, Shaham Y. Increased vulnerability to nicotine self-administration and relapse in alcoholnaive offspring of rats selectively bred for high alcohol intake. J Neurosci 2006; 26(6): 1872-1879.
32. Nowak KL, Ingraham CM, McKinzie DL, et al. An assessment of novelty-seeking behavior in alcohol-preferring and nonpreferring rats. Pharmacol Biochem Behav 2000; 66(1): 113-121.
33. Heyser CJ, Roberts AJ, Schulteis G, Koob GF. Central administration of an opiate antagonist decreases oral ethanol selfadministration in rats. Alcohol Clin Exp Res 1999; 23(9): 1468-1476.
34. Zhang M, Kelley AE. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology (Berl) 2002; 159(4): 415-423.
35. Barson JR, Carr AJ, Soun JE, et al. Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol Clin Exp Res 2010; 34(2): 214-222.
36. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 1993; 264(1): 489-495.
37. Phillips AG, LePiane FG. Reward produced by microinjection of (D-Ala2), Met5-enkephalinamide into the ventral tegmental area. Behav Brain Res 1982; 5(2): 225-229.
38. Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM. Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 2008 Nov; 28(48): 12672-12681.
39. Chang GQ, Barson JR, Karatayev O, Chang SY, Chen YW, Leibowitz SF. Effect of chronic ethanol on enkephalin in the hypothalamus and extra-hypothalamic areas. Alcohol Clin Exp Res 2010; 34(5): 761-770.
40. Mendez M, Morales-Mulia M. Ethanol exposure differentially alters pro-enkephalin mRNA expression in regions of the mesocorticolimbic system. Psychopharmacology (Berl) 2006; 189(1): 117-124.
41. de Gortari P, Mendez M, Rodriguez-Keller I, Perez-Martinez L, Joseph-Bravob P. Acute ethanol administration induces changes in TRH and proenkephalin expression in hypothalamic and limbic regions of rat brain. Neurochem Int 2000; 37(5-6): 483-496.
42. Chang GQ, Karatayev O, Ahsan R, et al. Effect of ethanol on hypothalamic opioid peptides, enkephalin, and dynorphin: relationship with circulating triglycerides. Alcohol Clin Exp Res 2007; 31(2): 249-259.
43. Oliva JM, Manzanares J. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats. Neuropsychopharmacology 2007; 32(6): 1358-1369.
44. Rada P, Avena NM, Leibowitz SF, Hoebel BG. Ethanol intake is increased by injection of galanin in the paraventricular nucleus and reduced by a galanin antagonist. Alcohol 2004; 33(2): 91-97.
45. Leibowitz SF, Avena NM, Chang GQ, Karatayev O, Chau DT, Hoebel BG. Ethanol intake increases galanin mRNA in the hypothalamus and withdrawal decreases it. Physiol Behav 2003; 79(1): 103-111.
46. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006; 148(6): 752-759.
47. Moorman DE, Aston-Jones G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in highethanol--preferring Sprague--Dawley rats. Alcohol 2009; 43(5): 379-386.
48. Richards JK, Simms JA, Steensland P, et al. Inhibition of orexin- 1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008; 1991(1): 109-117.
49. Duncan EA, Proulx K, Woods SC. Central administration of melanin-concentrating hormone increases alcohol and sucrose/quinine intake in rats. Alcohol Clin Exp Res 2005; 29(6): 958-964.
50. Morganstern I, Chang GQ, Barson JR, Ye Z, Karatayev O, Leibowitz SF. Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res 2010; 34(5): 886-896.
51. Badia-Elder NE, Stewart RB, Powrozek TA, Roy KF, Murphy JM, Li TK. Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. Alcohol Clin Exp Res 2001; 25(3): 386-390.
52. Lucas LA, McMillen BA. Effect of neuropeptide Y microinjected into the hypothalamus on ethanol consumption. Peptides 2004; 25(12): 2139-2145.
53. Kinoshita H, Jessop DS, Finn DP, et al. Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus. Neuroreport 2000; 11(16): 3517-3219.
54. Roy A, Pandey SC. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin Exp Res 2002; 26(6): 796-803.
55. Hayward MD, Hansen ST, Pintar JE, Low MJ. Operant selfadministration of ethanol in C57BL/6 mice lacking beta-endorphin and enkephalin. Pharmacol Biochem Behav 2004; 79(1): 171-181.
56. Koenig HN, Olive MF. Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin. Neurosci Lett 2002; 325(2): 75-78.
57. Hall FS, Sora I, Uhl GR. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl) 2001; 154(1): 43-49.
58. Jamensky NT, Gianoulakis C. Comparison of the proopiomelanocortin and proenkephalin opioid peptide systems in brain regions of the alcohol-preferring C57BL/6 and alcoholavoiding DBA/2 mice. Alcohol 1999; 18(2-3): 177-187.
59. Blum K, Briggs AH, DeLallo L, Elston SF, Ochoa R. Whole brain methionine-enkephalin of ethanol-avoiding and ethanol-preferring c57BL mice. Experientia 1982; 38(12): 1469-1470.
60. Blum K, Briggs AH, Trachtenberg MC, Delallo L, Wallace JE. Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice. Alcohol 1987; 4(6): 449-456.
61. Cowen M, Chen F, Jarrott B, Lawrence AJ. Effects of acute ethanol on GABA release and GABA(A) receptor density in the rat mesolimbic system. Pharmacol Biochem Behav 1998; 59(1): 51-57.
62. de Waele JP, Kiianmaa K, Gianoulakis C. Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther 1995; 275(1): 518-527.
63. McBride WJ, Chernet E, McKinzie DL, Lumeng L, Li TK. Quantitative autoradiography of mu-opioid receptors in the CNS of alcohol-naive alcohol-preferring P and -nonpreferring NP rats. Alcohol 1998; 16(4): 317-323.
64. Marinelli PW, Kiianmaa K, Gianoulakis C. Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats. Life Sci 2000; 66(20): 1915-1927.
65. Karatayev O, Baylan J, Leibowitz SF. Increased intake of ethanol and dietary fat in galanin overexpressing mice. Alcohol 2009; 43(8): 571-580.
66. Karatayev O, Baylan J, Weed V, Chang S, Wynick D, Leibowitz SF. Galanin knockout mice show disturbances in ethanol consumption and expression of hypothalamic peptides that stimulate ethanol intake. Alcohol Clin Exp Res 2010; 34(1): 72-80.
67. Belfer I, Hipp H, Bollettino A, et al. Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav 2007; 6(5): 473-481.
68. Belfer I, Hipp H, McKnight C, et al. Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 2006; 11(3): 301-311.
69. Duncan EA, Rider TR, Jandacek RJ, et al. The regulation of alcohol intake by melanin-concentrating hormone in rats. Pharmacol Biochem Behav.2006; 85(4): 728-735.
70. Thiele TE, Koh MT, Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci 2002; 22(3): RC208.
71. Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998; 396(6709): 366-369.
72. Hayes DM, Knapp DJ, Breese GR, Thiele TE. Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcohol Clin Exp Res 2005; 29(5): 721-729.
73. Hwang BH, Zhang JK, Ehlers CL, Lumeng L, Li TK. Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol Clin Exp Res 1999; 23(6): 1023-1030.
74. McKinzie DL, McBride WJ, Murphy JM, Lumeng L, Li TK. Effects of amphetamine on locomotor activity in adult and juvenile alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav 2002; 71(1-2): 29-36.
75. Bisaga A, Kostowski W. Individual behavioral differences and ethanol consumption in Wistar rats. Physiol Behav 1993; 54(6): 1125-1131.
76. Nadal R, Armario A, Janak PH. Positive relationship between activity in a novel environment and operant ethanol selfadministration in rats. Psychopharmacology (Berl) 2002; 162(3): 333-338.
77. Bienkowski P, Koros E, Kostowski W. Novelty-seeking behaviour and operant oral ethanol self-administration in Wistar rats. Alcohol Alcohol 2001; 36(6): 525-528.
78. Gingras MA, Cools AR. Differential ethanol intake in high and low responders to novelty. Behav Pharmacol 1995; 6(7): 718-723.
79. Karatayev O, Barson JR, Carr AJ, Baylan J, Chen YW, Leibowitz SF. Predictors of ethanol consumption in adult Sprague-Dawley rats: relation to hypothalamic peptides that stimulate ethanol intake. Alcohol 2010; 44(4): 323-334.
80. Colombo G, Agabio R, Lobina C, et al. Sardinian alcoholpreferring rats: a genetic animal model of anxiety. Physiol Behav 1995; 57(6): 1181-1185.
81. Stewart RB, Gatto GJ, Lumeng L, Li TK, Murphy JM. Comparison of alcohol-preferring (P) and nonpreferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol 1993; 10(1): 1-10.
82. Badia-Elder NE, Stewart RB, Powrozek TA, Murphy JM, Li TK. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. Alcohol Clin Exp Res 2003; 27(6): 894-899.
83. McMillen BA, Means LW, Matthews JN. Comparison of the alcohol-preferring P rat to the Wistar rat in behavioral tests of impulsivity and anxiety. Physiol Behav 1998; 63(3): 371-375.
84. Overstreet DH, Halikas JA, Seredenin SB, et al. Behavioral similarities and differences among alcohol-preferring and -nonpreferring rats: confirmation by factor analysis and extension to additional groups. Alcohol Clin Exp Res 1997; 21(5): 840-848.
85. Gosnell BA, Krahn DD. The relationship between saccharin and alcohol intake in rats. Alcohol 1992; 9(3): 203-206.
86. Overstreet DH, Kampov-Polevoy AB, Rezvani AH, Murrelle L, Halikas JA, Janowsky DS. Saccharin intake predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcohol Clin Exp Res 1993; 17(2): 366-369.
87. Rogowski A, Kostowski W, Bienkowski P. Sucrose selfadministration predicts only initial phase of ethanol-reinforced behaviour in Wistar rats. Alcohol Alcohol 2002; 37(5): 436-440.
88. Stewart RB, Russell RN, Lumeng L, Li TK, Murphy JM. Consumption of sweet, salty, sour, and bitter solutions by selectively bred alcohol-preferring and alcohol-nonpreferring lines of rats. Alcohol Clin Exp Res 1994; 18(2): 375-381.
89. Hooks MS, Sorg BA, Kalivas PW. The relationship between MRNA levels and the locomotor response to novelty. Brain Res 1994; 663(2): 312-316.
90. Kuteeva E, Hokfelt T, Ogren SO. Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoter. Regul Pept 2005; 125(1-3): 67-78.
91. Matsuo E, Mochizuki A, Nakayama K, et al. Decreased intake of sucrose solutions in orexin knockout mice. J Mol Neurosci 2011; 43(2): 217-224.
92. Karl T, Burne TH, Herzog H. Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav Brain Res 2006; 167(1): 87-93.
93. Bannon AW, Seda J, Carmouche M, et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 2000; 868(1): 79-87.
94. Bilkei-Gorzo A, Racz I, Michel K, Mauer D, Zimmer A, Klingmuller D. Control of hormonal stress reactivity by the endogenous opioid system. Psychoneuroendocrinology 2008; 33(4): 425-436.
95. Konig M, Zimmer AM, Steiner H, et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996; 383(6600): 535-538.
96. Ragnauth A, Schuller A, Morgan M, et al. Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci U S A 2001; 98(4): 1958-1963.
97. Guitart-Masip M, Gimenez-Llort L, Fernandez-Teruel A, et al. Reduced ethanol response in the alcohol-preferring RHA rats and neuropeptide mRNAs in relevant structures. Eur J Neurosci 2006; 23(2): 531-540.
98. Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN. Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav 2007; 86(1): 8-20.
99. Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides 2008; 42(4): 387-397.
100. Lyudyno VI, Abdurasulova IN, Klimenko VM. The role of the neuropeptide galanin in forming type-specific behavioral characteristics. Neurosci Behav Physiol 2008; 38(1): 93-98.
101. Roy M, David NK, Danao JV, Baribault H, Tian H, Giorgetti M. Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology 2006; 31(1): 112-120.
102. Smith DG, Davis RJ, Rorick-Kehn L, et al. Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 2006; 31(6): 1135-1145.
103. Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G. Increased novelty-induced motor activity and reduced depressionlike behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 2009; 158(4): 1717-1730.
104. Inui A, Okita M, Nakajima M, et al. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc Assoc Am Phys 1998; 110(3): 171-182.
105. Hayward MD, Pintar JE, Low MJ. Selective reward deficit in mice lacking beta-endorphin and enkephalin. J Neurosci 2002; 22(18): 8251-8258.
106. Thiele TE, Naveilhan P, Ernfors P. Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice. Peptides 2004; 25(6): 975-983.
107. Karatayev O, Gaysinskaya V, Chang GQ, Leibowitz SF. Circulating triglycerides after a high-fat meal: predictor of increased caloric intake, orexigenic peptide expression, and dietary obesity. Brain Res 2009; 1298: 111-122.
108. Dhatt RK, Gudehithlu KP, Wemlinger TA, Tejwani GA, Neff NH, Hadjiconstantinou M. Preproenkephalin mRNA and methionineenkephalin content are increased in mouse striatum after treatment with nicotine. J Neurochem 1991; 64(4): 1878-1883.
109. Houdi AA, Dasgupta R, Kindy MS. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 1998; 799(2): 257-263.
110. Loughlin SE, Islas MI, Cheng MY, Lee AG, Villegier AS, Leslie FM. Nicotine modulation of stress-related peptide neurons. J Comp Neurol 2006; 497(4): 575-588.
111. Hollt V, Horn G. Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat. Clin Investig 1992; 70(3-4): 224-231.
112. Wewers ME, Dhatt RK, Snively TA, Tejwani GA. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats. Brain Res 1999; 822(1-2): 107-113.
113. Balerio GN, Aso E, Maldonado R. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 2005; 181(2): 260-269.
114. Ismayilova N, Shoaib M. Alteration of intravenous nicotine selfadministration by opioid receptor agonist and antagonists in rats. Psychopharmacology (Berl) 2010; 210(2): 211-220.
115. Kane JK, Parker SL, Matta SG, Fu Y, Sharp BM, Li MD. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology 2000; 141(10): 3623-3629.
116. Pasumarthi RK, Reznikov LR, Fadel J. Activation of orexin neurons by acute nicotine. Eur J Pharmacol 2006; 535(1-3): 172-176.
117. Plaza-Zabala A, Martin-Garcia E, de Lecea L, Maldonado R, Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 2010; 30(6): 2300-2310.
118. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 2008; 105(49): 19480-19485.
119. LeSage MG, Perry JL, Kotz CM, Shelley D, Corrigall WA. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology (Berl) 2010; 209(2): 203-212.
120. Frankish HM, Dryden S, Wang Q, Bing C, MacFarlane IA, Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Res 1995; 694(1-2): 139-146.
121. Slawecki CJ, Thorsell AK, El Khoury A, Mathe AA, Ehlers CL. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides 2005; 39(4): 369-377.
122. Abreu-Villaca Y, Queiroz-Gomes Fdo E, Dal Monte AP, Filgueiras CC, Manhaes AC. Individual differences in novelty-seeking behavior but not in anxiety response to a new environment can predict nicotine consumption in adolescent C57BL/6 mice. Behav Brain Res 2006; 167(1): 175-182.
123. Chattopadhyay K, Chattopadhyay BD. Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein. Indian J Med Res 2008; 127(6): 571-576.
124. Sreekala S, Indira M. Effect of exogenous selenium on nicotine induced hyperlipidemia in rats. Indian J Physiol Pharmacol 2008; 52(2): 132-140.
125. Chang GQ, Karatayev O, Ahsan R, Gaysinskaya V, Marwil Z, Leibowitz SF. Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides. Am J Physiol Endocrinol Metab 2007; 292(2): E561-E570.
126. Shor-Posner G, Brennan G, Ian C, Jasaitis R, Madhu K, Leibowitz SF. Meal patterns of macronutrient intake in rats with particular dietary preferences. Am J Physiol 1994; 266(4 Pt 2): R1395-R1402.
127. Burggraf KK, Willing AE, Koopmans HS. The effects of glucose or lipid infused intravenously or intragastrically on voluntary food intake in the rat. Physiol Behav 1997; 61(6): 787-793.
128. Gaysinskaya VA, Karatayev O, Chang GQ, Leibowitz SF. Increased caloric intake after a high-fat preload: relation to circulating triglycerides and orexigenic peptides. Physiol Behav 2007; 91(1): 142-153.
129. Lucas F, Ackroff K, Sclafani A. High-fat diet preference and overeating mediated by postingestive factors in rats. Am J Physiol 1998; 275(5 Pt 2): R1511-R1522.
130. Yanovski S. Sugar and fat: cravings and aversions. J Nutr 2003; 133(3): 835S-837S.
131. McLean S, Hoebel BG. Feeding induced by opiates injected into the paraventricular hypothalamus. Peptides 1983; 4(3): 287-292.
132. Cador M, Kelley AE, Le Moal M, Stinus L. Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience 1986; 18(3): 659-669.
133. MacDonald AF, Billington CJ, Levine AS. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol Regul Integr Comp Physiol 2003; 285(5): R999-R1004.
134. Mucha RF, Iversen SD. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res 1986; 397(2): 214-224.
135. Gosnell BA. Involvement of mu opioid receptors in the amygdale in the control of feeding. Neuropharmacology 1988; 27(3): 319-326.
136. Mena JD, Sadeghian K, Baldo BA. Induction of hyperphagia and carbohydrate intake by mu-opioid receptor stimulation in circumscribed regions of frontal cortex. J Neurosci 2011; 31(9): 3249-3260.
137. Glass MJ, Billington CJ, Levine AS. Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. Am J Physiol Regul Integr Comp Physiol 2000; 279(1): R86-R92.
138. Naleid AM, Grace MK, Chimukangara M, Billington CJ, Levine AS. Paraventricular opioids alter intake of high-fat but not highsucrose diet depending on diet preference in a binge model of feeding. Am J Physiol Regul Integr Comp Physiol 2007; 293(1): R99-R105.
139. Zhang M, Gosnell BA, Kelley AE. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 1998; 285(2): 908-914.
140. Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 1990; 11(5): 995-1001.
141. Smith BK, York DA, Bray GA. Effects of dietary preference and galanin administration in the paraventricular or amygdaloid nucleus on diet self-selection. Brain Res Bull 1996; 39(3): 149-154.
142. Nagase H, Nakajima A, Sekihara H, York DA, Bray GA. Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions. J Gastroenterol 2002; 37(Suppl 14): 118-127.
143. Tempel DL, Leibowitz KJ, Leibowitz SF. Effects of PVN galanin on macronutrient selection. Peptides 1988; 9(2): 309-314.
144. Akabayashi A, Koenig JI, Watanabe Y, Alexander JT, Leibowitz SF. Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci U S A 1994; 91(22): 10375-10379.
145. Leibowitz SF, Akabayashi A, Wang J. Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci 1998; 18(7): 2709-2719.
146. Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev 2005; 9(4): 231-241.
147. Cai XJ, Widdowson PS, Harrold J, et al. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 1999; 48(11): 2132-2137.
148. Dube MG, Kalra SP, Kalra PS. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 1999; 842(2): 473-477.
149. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 1999; 160(3): R7-R12.
150. Sweet DC, Levine AS, Billington CJ, Kotz CM. Feeding response to central orexins. Brain Res 1999; 821(2): 535-538.
151. Thorpe AJ, Kotz CM. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res 2005; 1050(1-2): 156-162.
152. Clegg DJ, Air EL, Woods SC, Seeley RJ. Eating elicited by orexina, but not melanin-concentrating hormone, is opioid mediated. Endocrinology 2002; 143(8): 2995-3000.
153. Park ES, Yi SJ, Kim JS, et al. Changes in orexin-A and neuropeptide Y expression in the hypothalamus of the fasted and high-fat diet fed rats. J Vet Sci 2004; 5(4): 295-302.
154. Wortley KE, Chang GQ, Davydova Z, Leibowitz SF. Peptides that regulate food intake: orexin gene expression is increased during states of hypertriglyceridemia. Am J Physiol Regul Integr Comp Physiol 2003; 284(6): R1454-R1465.
155. Griffond B, Risold PY, Jacquemard C, Colard C, Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 1999; 262(2): 77-80.
156. Harthoorn LF, Sane A, Nethe M, Van Heerikhuize JJ. Multitranscriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell Mol Neurobiol 2005; 25(8): 1209-1223.
157. Qu D, Ludwig DS, Gammeltoft S, et al. A role for melaninconcentrating hormone in the central regulation of feeding behaviour. Nature 1996; 380(6571): 243-247.
158. Guesdon B, Paradis E, Samson P, Richard D. Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. Am J Physiol Regul Integr Comp Physiol 2009; 296(3): R469-R475.
159. Rossi M, Beak SA, Choi SJ, et al. Investigation of the feeding effects of melanin concentrating hormone on food intake-action independent of galanin and the melanocortin receptors. Brain Res 1999; 846(2): 164-170.
160. Gomori A, Ishihara A, Ito M, et al. Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. Am J Physiol Endocrinol Metab 2003; 284(3): E583-E588.
161. Benoit SC, Clegg DJ, Woods SC, Seeley RJ. The role of previous exposure in the appetitive and consummatory effects of orexigenic neuropeptides. Peptides 2005; 26(5): 751-757.
162. Sakamaki R, Uemoto M, Inui A, et al. Melanin-concentrating hormone enhances sucrose intake. Int J Mol Med 2005; 15(6): 1033-1039.
163. Elliott JC, Harrold JA, Brodin P, et al. Increases in melaninconcentrating hormone and MCH receptor levels in the hypothalamus of dietary-obese rats. Brain Res Mol Brain Res 2004; 128(2): 150-159.
164. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A 1991; 88(23): 10931-10935.
165. Marks JL, Li M, Schwartz M, Porte D, Jr., Baskin DG. Effect of fasting on regional levels of neuropeptide Y mRNA and insulin receptors in the rat hypothalamus: An autoradiographic study. MolCell Neurosci 1992; 3(3): 199-205.
166. Stanley BG, Chin AS, Leibowitz SF. Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res Bull 1985; 14(6): 521-524.
167. Stanley BG, Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 1984; 35(26): 2635-2642.
168. Brown CM, Fletcher PJ, Coscina DV. Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine. Peptides 1998; 19(10): 1667-1673.
169. Chang GQ, Karatayev O, Davydova Z, Wortley K, Leibowitz SF. Glucose injection reduces neuropeptide Y and agouti-related protein expression in the arcuate nucleus: a possible physiological role in eating behavior. Brain Res Mol Brain Res 2005; 135(1-2): 69-80.
170. Lindqvist A, Baelemans A, Erlanson-Albertsson C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept 2008; 150(1-3): 26-32.
171. Giraudo SQ, Kotz CM, Grace MK, Levine AS, Billington CJ. Rat hypothalamic NPY mRNA and brown fat uncoupling protein mRNA after high-carbohydrate or high-fat diets. Am J Physiol 1994; 266(5 Pt 2): R1578-R1583.
172. Wang J, Akabayashi A, Dourmashkin J, et al. Neuropeptide Y in relation to carbohydrate intake, corticosterone and dietary obesity. Brain Res 1998; 802(1-2): 75-88.
173. Hayward MD, Low MJ. The contribution of endogenous opioids to food reward is dependent on sex and background strain. Neuroscience 2007; 144(1): 17-25.
174. Hayward MD, Schaich-Borg A, Pintar JE, Low MJ. Differential involvement of endogenous opioids in sucrose consumption and food reinforcement. Pharmacol Biochem Behav 2006; 85(3): 601-611.
175. Hohmann JG, Krasnow SM, Teklemichael DN, Clifton DK, Wynick D, Steiner RA. Neuroendocrine profiles in galaninoverexpressing and knockout mice. Neuroendocrinol 2003; 77(6): 354-366.
176. Adams AC, Clapham JC, Wynick D, Speakman JR. Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference. J Neuroendocrinol 2008; 20(2): 199-206.
177. Akiyama M, Yuasa T, Hayasaka N, Horikawa K, Sakurai T, Shibata S. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur J Neurosci 2004; 20(11): 3054-3062.
178. Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010; 67(8): 753-760.
179. Kaur S, Thankachan S, Begum S, et al. Entrainment of temperature and activity rhythms to restricted feeding in orexin knock out mice. Brain Res 2008; 1205: 47-54.
180. Alon T, Friedman JM. Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. J Neurosci 2006; 26(2): 389-397.
181. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 1998 Dec 17; 396(6712): 670-674.
182. Ludwig DS, Tritos NA, Mastaitis JW, et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 2001; 107(3): 379-386.
183. Edelsbrunner ME, Painsipp E, Herzog H, Holzer P. Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake. Neuropeptides 2009; 43(6): 491-497.
184. Patel HR, Qi Y, Hawkins EJ, et al. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Diabetes 2006; 55(11): 3091-3098.
185. Kaga T, Inui A, Okita M, et al. Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes 2001; 50(5): 1206-1210.
186. Morganstern I, Chang GQ, Karatayev O, Leibowitz SF. Increased orexin and melanin-concentrating hormone expression in the perifornical lateral hypothalamus of rats prone to overconsuming a fat-rich diet. Pharmacol Biochem Behav 2010; 96(4): 413-422.
187. Gosnell BA, Mitra A, Avant RA, Anker JJ, Carroll ME, Levine AS. Operant responding for sucrose by rats bred for high or low saccharin consumption. Physiol Behav 2010; 99(4): 529-533.
188. Hendley ED, Conti LH, Wessel DJ, Horton ES, Musty RE. Behavioral and metabolic effects of sucrose-supplemented feeding in hyperactive rats. Am J Physiol 1987; 253(3 Pt 2): R434-R443.
189. Odorizzi M, Max JP, Tankosic P, Burlet C, Burlet A. Dietary preferences of Brattleboro rats correlated with an overexpression of galanin in the hypothalamus. Eur J Neurosci 1999; 11(9): 3005-3014.
190. Rokaeus A, Young WS, 3rd, Mezey E. Galanin coexists with vasopressin in the normal rat hypothalamus and galanin's synthesis is increased in the Brattleboro (diabetes insipidus) rat. Neurosci Lett 1988; 90(1-2): 45-50.
191. Beck B, Max JP. Neuropeptide Y in the arcuato-paraventricular pathway and diet selection in the vasopressin-deficient Brattleboro rat. Brain Res Bull 2008; 76(4): 454-457.
192. Barson JR, Fagan SE, Leibowitz SF. Hypothalamic peptides are altered in rats predicted to consume fat or ethanol. Abstracts of the 19th Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), 12-16 July 2011, Clearwater, Florida 2011; 57(Supplement): S4.